Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neonatology

Free Subscription Articles published in Transfusion Retrieve available abstracts of 49 articles: HTML format

Single Articles

July 2026
1. FENG J, Tian L, Zhang Y, Zhu K, et al
   A novel homozygous ABCB6 variant causing the Lan null phenotype and anti-Lan-mediated hemolytic disease of the fetus and newborn: A case report and a review of anti-Lan in pregnancy.
   Transfusion. 2026 Jul 10. doi: 10.1111/trf.70319.
   PubMed     Abstract available
   
   
   June 2026
2. BARTON R, Van Den Helm S, Yaw HP, Attard C, et al
   Transfusion of blood products to neonatal and pediatric extracorporeal membrane oxygenation patients: A prospective, observational study.
   Transfusion. 2026 Jun 18. doi: 10.1111/trf.70154.
   PubMed     Abstract available
   
   
   
3. LU W, Ziman A, Yin C, Yan MTS, et al
   Clinical significance of anti-M in pregnancy and self-reported ancestry: The BEST collaborative study.
   Transfusion. 2026;66:1086-1098.
   PubMed     Abstract available
   
   
   May 2026
4. DEROUBAIX E, Emektas MH, Alluin G, Renom P, et al
   Maternal-fetal platelet alloimmunization: Identification of risk factors for severe neonatal thrombocytopenia.
   Transfusion. 2026 May 25. doi: 10.1111/trf.70234.
   PubMed     Abstract available
   
   
   
5. LANGE K, Bowers A, Raghavan N, Borland H, et al
   Early exposure, enduring consequences: How do I manage Rh immunoglobulin prophylaxis after Rh-mismatched transfusions in children?
   Transfusion. 2026;66 Suppl 1.
   PubMed     Abstract available
   
   
   April 2026
6. PELLEGRINO C, Papacci P, Dani C, Cresi F, et al
   Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial.
   Transfusion. 2026 Apr 29. doi: 10.1111/trf.70241.
   PubMed     Abstract available
   
   
   
7. NORTH A, Corash L, Benjamin RJ, Mufti N, et al
   Safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal rats.
   Transfusion. 2026 Apr 24. doi: 10.1111/trf.70240.
   PubMed     Abstract available
   
   
   
8. KATARZYNA G, Malgorzata U, Agnieszka O, Marzena D, et al
   HPA-1a alloimmunization and pregnancy outcome in a Polish screening program: PREVFNAIT.
   Transfusion. 2026;66:814-827.
   PubMed     Abstract available
   
   
   March 2026
9. CHOOI CSL, Simmonds MC, Fisher L, Crawford T, et al
   Management of neonatal massive hemorrhage: A narrative review.
   Transfusion. 2026 Mar 17. doi: 10.1111/trf.70186.
   PubMed    
   
   
   February 2026
10. SHERWOOD M, Weathersby B, Moise K Jr, Gonzalez-Velez J, et al
    A critical moment: Standardizing red blood cell antibody reporting to reduce hemolytic disease of the fetus and newborn risk.
    Transfusion. 2026 Feb 16. doi: 10.1111/trf.70124.
    PubMed    
    
    
    January 2026
11. KADIOGLU SIMSEK G, Siyah Bilgin B, Kalayci OK, Tekin MY, et al
    Transfusion of blood products and neonatal outcomes in preterm infants: A retrospective cohort study.
    Transfusion. 2026 Jan 26. doi: 10.1111/trf.70064.
    PubMed     Abstract available
    
    
    
12. ALDARWEESH FA, Abdallah R, Alvarez IP, Andrews J, et al
    D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative Study.
    Transfusion. 2026;66:94-101.
    PubMed     Abstract available
    
    
    December 2025
13. DE WINTER DP, de Haas M, Hulzebos CV, Lukens MV, et al
    Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study.
    Transfusion. 2025 Dec 30. doi: 10.1111/trf.70056.
    PubMed     Abstract available
    
    
    
14. VAN DAELEN JH, Bestebroer J, Korsten H, Vermeulen C, et al
    Development and production of allogeneic cord blood-derived red blood cell concentrates for transfusion to extremely preterm neonates, the All-Cord study.
    Transfusion. 2025 Dec 22. doi: 10.1111/trf.70024.
    PubMed     Abstract available
    
    
    
15. DAVENPORT P, Feldman HA, Kane N, Escobar JR, et al
    Transfusion of adult platelets triggers inflammatory responses in newborn mice through both P-selectin-dependent and -independent mechanisms.
    Transfusion. 2025 Dec 16. doi: 10.1111/trf.70042.
    PubMed     Abstract available
    
    
    
16. RAJ JG, Shrestha P, Ramatchandirin B, Balamurugan MA, et al
    Red blood cell transfusion exacerbates phlebotomy-induced anemia-associated neuroinflammation in murine neonates.
    Transfusion. 2025 Dec 3. doi: 10.1111/trf.70018.
    PubMed     Abstract available
    
    
    
17. O'BRIEN K, Abels E, Bakhtary S, George M, et al
    A survey on the use of Rh immune globulin during a nationwide shortage.
    Transfusion. 2025;65:2286-2292.
    PubMed     Abstract available
    
    
    
18. BLACKALL D, Alcorn K, Parikh P
    Successful outcome of a pregnancy complicated by anti-e and anti-Di(b).
    Transfusion. 2025;65:2423-2426.
    PubMed     Abstract available
    
    
    October 2025
19. NOGUEIRA-SILVA LC, Bordin JO, Abbas SA, Lopes LB, et al
    Concurrent neonatal alloimmune neutropenia and thrombocytopenia: Prevalence and antibody specificity and intensity in a large Brazilian cohort.
    Transfusion. 2025 Oct 5. doi: 10.1111/trf.18429.
    PubMed     Abstract available
    
    
    September 2025
20. HOUBEN NAM, Caram-Deelder C, Lopriore E, Fustolo-Gunnink S, et al
    The whole is greater than the sum of its parts: Rethinking our approach to neonatal transfusion research.
    Transfusion. 2025 Sep 30. doi: 10.1111/trf.18432.
    PubMed     Abstract available
    
    
    
21. PRAKASH S, Verma A, Sehgal T, Aggarwal M, et al
    Hematological and iron status in infants with Rh hemolytic disease: A prospective cohort study.
    Transfusion. 2025 Sep 25. doi: 10.1111/trf.18430.
    PubMed     Abstract available
    
    
    
22. KELLY E, Rosenberg M, Gonzalez-Velez J, Bakhtary S, et al
    Characterization of a population with pregnancy potential and anti-K alloimmunization in the United States.
    Transfusion. 2025;65:1567-1573.
    PubMed     Abstract available
    
    
    August 2025
23. GONZALEZ-RESINA R, Herrero-Gutierrez M, Gomez-Segui I, Martinez-Nieto J, et al
    Rare onset of congenital thrombotic thrombocytopenic purpura during pregnancy: A novel ADAMTS13 gene variant.
    Transfusion. 2025 Aug 19. doi: 10.1111/trf.18379.
    PubMed     Abstract available
    
    
    
24. TRUCCO BOGGIONE C, Benech C, Pigozzi MJ, Orlandi MF, et al
    Alloanti-D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling.
    Transfusion. 2025 Aug 3. doi: 10.1111/trf.18369.
    PubMed     Abstract available
    
    
    June 2025
25. LAMOTHE M, Beltempo M, Lapointe A, Villeneuve A, et al
    Current red blood cell and platelet transfusion practices in Canadian neonatal intensive care units.
    Transfusion. 2025 Jun 9. doi: 10.1111/trf.18305.
    PubMed     Abstract available
    
    
    May 2025
26. ALKHATEB R, Mazzolini K, Prajapati VP, Harrison C, et al
    How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood.
    Transfusion. 2025;65 Suppl 1:S320-S327.
    PubMed     Abstract available
    
    
    April 2025
27. GREGER N, Xu XZ, Doescher A, Hassenpflug W, et al
    Alloimmunization against platelet-specific antigen Dik on glycoprotein IIb in a case of fetal-neonatal alloimmune thrombocytopenia.
    Transfusion. 2025 Apr 17. doi: 10.1111/trf.18194.
    PubMed    
    
    
    
28. BABACAN A, Sarklioglu SS, Cavus K, Sarici SU, et al
    Several features of newborns following intrauterine intravascular blood transfusion for fetal hemolytic disease caused by anti-D alloimmunization.
    Transfusion. 2025 Apr 10. doi: 10.1111/trf.18248.
    PubMed     Abstract available
    
    
    
29. GREEN RW, Cotton BA
    Neonatal trauma resuscitation: Successful use of low-titer O+ whole blood in a 4-day-old infant with hemorrhagic shock.
    Transfusion. 2025 Apr 9. doi: 10.1111/trf.18233.
    PubMed     Abstract available
    
    
    
30. MADHOU A, Lloyd LG, Mundey N, Nell EM, et al
    Adverse outcomes after red blood cell transfusion in very low birth weight infants in a resource-restricted hospital.
    Transfusion. 2025 Apr 7. doi: 10.1111/trf.18244.
    PubMed     Abstract available
    
    
    March 2025
31. WILHELM K, Lauer C, Rangwala R, Zadeh T, et al
    A prehospital protocol for transfusion of low-titer O-positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn.
    Transfusion. 2025 Mar 1. doi: 10.1111/trf.18184.
    PubMed     Abstract available
    
    
    January 2025
32. NELSON O, Jones R, Moldenhauer JS, Rintoul NE, et al
    Cord blood for autologous transfusion in infants with congenital anomalies: Volumes, sterility, and stability during storage.
    Transfusion. 2025 Jan 14. doi: 10.1111/trf.18134.
    PubMed     Abstract available
    
    
    
33. DELBAUGH RM, Thomas B, Gower BJ, Condict B, et al
    Double trouble: A baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune thrombocytopenia.
    Transfusion. 2025 Jan 4. doi: 10.1111/trf.18120.
    PubMed    
    
    
    
34. THORUP E, Clausen FB, Brodersen T, Dellgren CD, et al
    Evaluation of the clinical effect of a nationwide implementation of targeted routine antenatal anti-D prophylaxis in Denmark.
    Transfusion. 2025;65:29-37.
    PubMed     Abstract available
    
    
    December 2024
35. ADKINS BD, Booth GS, Fasano RM, Gehrie EA, et al
    Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm-changing practice?
    Transfusion. 2024 Dec 22. doi: 10.1111/trf.18113.
    PubMed    
    
    
    
36. BIENZ M, Constanzo-Yanez J, Baillargeon N, Leiva-Torres GA, et al
    Planning antepartum directed donations in preparation for neonatal cardiac surgery in the absence of compatible donors.
    Transfusion. 2024 Dec 2. doi: 10.1111/trf.18087.
    PubMed     Abstract available
    
    
    October 2024
37. JACOBS JW, Booth GS, Moise KJ, Adkins BD, et al
    Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States.
    Transfusion. 2024;64:1870-1880.
    PubMed     Abstract available
    
    
    September 2024
38. GRISELLI M, Said SM, Spinella PC, Evans M, et al
    Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass.
    Transfusion. 2024 Sep 13. doi: 10.1111/trf.18014.
    PubMed     Abstract available
    
    
    July 2024
39. YAZER MH, Spinella PC, Holcomb JB, Horvath S, et al
    A review of attitudes to urgent RhD-positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn.
    Transfusion. 2024 Jul 23. doi: 10.1111/trf.17967.
    PubMed    
    
    
    June 2024
40. BERTRAND G, Danger Y, Verite F, Sarpentier Guibourg M, et al
    A new platelet alloantigen (Efs(2a)) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.
    Transfusion. 2024 Jun 25. doi: 10.1111/trf.17933.
    PubMed    
    
    
    
41. GILMORE LE, Chou ST, Ghavam S, Thom CS, et al
    Consensus transfusion guidelines for a large neonatal intensive care network.
    Transfusion. 2024 Jun 17. doi: 10.1111/trf.17914.
    PubMed    
    
    
    May 2024
42. 
    Correction to Comparison of Automated Solid Phase vs Manual Saline Indirect Antiglobulin Test Methodology for non-ABO Antibody Titration: Implications for Perinatal Antibody Monitoring.
    Transfusion. 2024 May 8. doi: 10.1111/trf.17866.
    PubMed    
    
    
    
43. PETERMANN R, Bianchi F, Saib L, Ferre N, et al
    Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother.
    Transfusion. 2024 May 1. doi: 10.1111/trf.17863.
    PubMed     Abstract available
    
    
    
44. SHERWOOD MR, Clayton S, Leeper CM, Yazer M, et al
    Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Transfusion. 2024;64 Suppl 2:S100-S110.
    PubMed     Abstract available
    
    
    
45. MALONE JR
    Ethical considerations in the use of RhD-positive blood products in trauma.
    Transfusion. 2024;64 Suppl 2:S4-S10.
    PubMed     Abstract available
    
    
    
46. SUSILA S, Ilmakunnas M, Lauronen J, Vuorinen P, et al
    Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Transfusion. 2024;64 Suppl 2:S119-S125.
    PubMed     Abstract available
    
    
    
47. OOSTERHOFF JJ, Linty F, Visser R, de Vos T, et al
    Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Transfusion. 2024;64:893-905.
    PubMed     Abstract available
    
    
    April 2024
48. WILSON B, Davison CL, Lopez GH, Millard GM, et al
    A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
    Transfusion. 2024 Apr 30. doi: 10.1111/trf.17205.
    PubMed     Abstract available
    
    
    
49. HEEGER LE, Houben NAM, Caram-Deelder C, Fustolo-Gunnink SF, et al
    Impact of restrictive platelet transfusion strategies on transfusion rates: A cohort study in very preterm infants.
    Transfusion. 2024 Apr 25. doi: 10.1111/trf.17844.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neonatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum